Chinese english Germany Japanese Korea

eIF4A3-IN-2

eIF4A3-IN-2 Struktur
2095677-20-4
CAS-Nr.
2095677-20-4
Englisch Name:
eIF4A3-IN-2
Synonyma:
eIF4A3-IN-2;eIF4A3 inhibitor 2;eIF4A3 IN 2,eIF-4A3-IN-2,eIF4A3IN2;Methanone, [(3S)-4-(4-bromobenzoyl)-3-(4-chlorophenyl)-1-piperazinyl](6-bromopyrazolo[1,5-a]pyridin-3-yl)-
CBNumber:
CB04667874
Summenformel:
C25H19Br2ClN4O2
Molgewicht:
602.71
MOL-Datei:
2095677-20-4.mol
Request For Quotation

eIF4A3-IN-2 Eigenschaften

Dichte
1.68±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMSO : 100 mg/mL (165.92 mM; Need ultrasonic)
Aggregatzustand
Solid
pka
0.89±0.30(Predicted)
Farbe
White to light yellow

Sicherheit

eIF4A3-IN-2 Chemische Eigenschaften,Einsatz,Produktion Methoden

eIF4A3-IN-2 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

eIF4A3-IN-2 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 10)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 52927 58
DC Chemicals 021-58447131 13564518121
 sales@dcchemicals.com China 9412 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
 sales@chemegen.com China 11289 58
Shanghai hongqu biomedical technology co. LTD 88888888888
 hongquchem@qq.com China 5132 58
Kaifeng Mingren Pharmaceutical Co.,LTD 0371-65741762
sales@hasunny.com China 2380 58
TargetMol Chemicals Inc. 4008200310
 marketing@tsbiochem.com China 23980 58
RD International Technology Co., Limited 18024082417
 market@ubiochem.com China 9268 58
Nanjing Shizhou Biology Technology Co.,Ltd 025-85560043 15850508050
 cindy.huang@synzest.com China 12007 58
  • eIF4A3-IN-2
  • eIF4A3 inhibitor 2
  • Methanone, [(3S)-4-(4-bromobenzoyl)-3-(4-chlorophenyl)-1-piperazinyl](6-bromopyrazolo[1,5-a]pyridin-3-yl)-
  • eIF4A3 IN 2,eIF-4A3-IN-2,eIF4A3IN2
  • 2095677-20-4
  • C25H19Br2ClN4O2
Copyright 2019 © ChemicalBook. All rights reserved